Xvivo Perfusion AB (publ) (0RKL.L)
SEK 461.69
(1.25%)
SEK 461.69
(1.25%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 91.82 Million SEK | 398.29% |
| 2022 | 18.42 Million SEK | 126.04% |
| 2021 | 8.15 Million SEK | 118.64% |
| 2020 | -43.73 Million SEK | -985.5% |
| 2019 | 4.93 Million SEK | -61.06% |
| 2018 | 12.68 Million SEK | 102.64% |
| 2017 | 6.26 Million SEK | 317.06% |
| 2016 | 1.5 Million SEK | -70.75% |
| 2015 | 5.13 Million SEK | 37.27% |
| 2014 | 3.73 Million SEK | -53.59% |
| 2013 | 8.05 Million SEK | 1147.33% |
| 2012 | -769 Thousand SEK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 85.81 Million SEK | 215.58% |
| 2024 Q1 | 22.78 Million SEK | -66.72% |
| 2024 Q2 | 27.19 Million SEK | 19.35% |
| 2023 Q4 | 68.47 Million SEK | 2897.99% |
| 2023 Q3 | 2.28 Million SEK | -66.83% |
| 2023 Q2 | 6.88 Million SEK | -51.42% |
| 2023 FY | 91.82 Million SEK | 398.29% |
| 2023 Q1 | 14.17 Million SEK | 1831.34% |
| 2022 Q2 | 7.53 Million SEK | 58.03% |
| 2022 FY | 18.42 Million SEK | 126.04% |
| 2022 Q4 | 734 Thousand SEK | -86.4% |
| 2022 Q3 | 5.39 Million SEK | -28.31% |
| 2022 Q1 | 4.76 Million SEK | -60.91% |
| 2021 Q4 | 12.18 Million SEK | 1179.63% |
| 2021 FY | 8.15 Million SEK | 118.64% |
| 2021 Q3 | -1.12 Million SEK | 87.37% |
| 2021 Q2 | -8.94 Million SEK | -248.2% |
| 2021 Q1 | 6.03 Million SEK | 130.82% |
| 2020 FY | -43.73 Million SEK | -985.5% |
| 2020 Q4 | -19.57 Million SEK | -33.3% |
| 2020 Q3 | -14.68 Million SEK | 8.32% |
| 2020 Q2 | -16.01 Million SEK | -344.81% |
| 2020 Q1 | 6.54 Million SEK | 444.01% |
| 2019 Q2 | 2.22 Million SEK | 806.98% |
| 2019 Q3 | 4.92 Million SEK | 121.33% |
| 2019 Q4 | -1.9 Million SEK | -138.59% |
| 2019 FY | 4.93 Million SEK | -61.06% |
| 2019 Q1 | -315 Thousand SEK | -106.45% |
| 2018 FY | 12.68 Million SEK | 102.64% |
| 2018 Q4 | 4.88 Million SEK | 4834.34% |
| 2018 Q3 | 99 Thousand SEK | -97.46% |
| 2018 Q2 | 3.89 Million SEK | 2.29% |
| 2018 Q1 | 3.8 Million SEK | -31.6% |
| 2017 Q1 | -45 Thousand SEK | 92.47% |
| 2017 Q2 | 1.09 Million SEK | 2522.22% |
| 2017 Q4 | 5.56 Million SEK | 1685.75% |
| 2017 FY | 6.26 Million SEK | 317.06% |
| 2017 Q3 | -351 Thousand SEK | -132.2% |
| 2016 Q2 | 1.52 Million SEK | 36.45% |
| 2016 Q3 | -535 Thousand SEK | -135.2% |
| 2016 Q4 | -598 Thousand SEK | -11.78% |
| 2016 FY | 1.5 Million SEK | -70.75% |
| 2016 Q1 | 1.11 Million SEK | -70.26% |
| 2015 Q2 | 1.28 Million SEK | 225.44% |
| 2015 Q4 | 3.74 Million SEK | 232.98% |
| 2015 Q3 | 1.12 Million SEK | -12.25% |
| 2015 Q1 | -1.02 Million SEK | -227.56% |
| 2015 FY | 5.13 Million SEK | 37.27% |
| 2014 Q1 | 1.82 Million SEK | -22.97% |
| 2014 FY | 3.73 Million SEK | -53.59% |
| 2014 Q2 | 752 Thousand SEK | -58.7% |
| 2014 Q3 | 1.47 Million SEK | 96.41% |
| 2014 Q4 | -312 Thousand SEK | -121.12% |
| 2013 Q2 | 1.71 Million SEK | -28.63% |
| 2013 Q3 | 1.57 Million SEK | -8.0% |
| 2013 FY | 8.05 Million SEK | 1147.33% |
| 2013 Q4 | 2.36 Million SEK | 50.0% |
| 2013 Q1 | 2.4 Million SEK | 412.09% |
| 2012 Q4 | -769 Thousand SEK | 0.0% |
| 2012 FY | -769 Thousand SEK | 0.0% |
| Name | Net Income | Net Income Difference |
|---|